Cargando…

DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION

Baseline plasma Cortisol levels and response to dexamethasone in a group of twenty five patients with ma) or depressive disorder (MDD) and a control group of twenty five patients with psychiatric diagnoses other than MDD were estimated. The results of our study show that dexamethasone suppression te...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, M. Saikumar, Kuruvilla, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 1986
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172529/
https://www.ncbi.nlm.nih.gov/pubmed/21927174
_version_ 1782211892602732544
author Reddy, M. Saikumar
Kuruvilla, K.
author_facet Reddy, M. Saikumar
Kuruvilla, K.
author_sort Reddy, M. Saikumar
collection PubMed
description Baseline plasma Cortisol levels and response to dexamethasone in a group of twenty five patients with ma) or depressive disorder (MDD) and a control group of twenty five patients with psychiatric diagnoses other than MDD were estimated. The results of our study show that dexamethasone suppression test (DST) is a useful diagnostic aid in MDD with melancholia with a sensitivity of 46% and specificity of 96%. Nonsuppression to DST is a marker of the state of melancholia and is not influenced by any other demographic or clinical variable. In our study 4 p.m. sample alone identified all the DST positive patients. MDD with melancholia showed significantly higher percentage of Cottisol hypersecretion and all non-suppressors were hypersecretors.
format Online
Article
Text
id pubmed-3172529
institution National Center for Biotechnology Information
language English
publishDate 1986
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-31725292011-09-16 DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION Reddy, M. Saikumar Kuruvilla, K. Indian J Psychiatry Original Article Baseline plasma Cortisol levels and response to dexamethasone in a group of twenty five patients with ma) or depressive disorder (MDD) and a control group of twenty five patients with psychiatric diagnoses other than MDD were estimated. The results of our study show that dexamethasone suppression test (DST) is a useful diagnostic aid in MDD with melancholia with a sensitivity of 46% and specificity of 96%. Nonsuppression to DST is a marker of the state of melancholia and is not influenced by any other demographic or clinical variable. In our study 4 p.m. sample alone identified all the DST positive patients. MDD with melancholia showed significantly higher percentage of Cottisol hypersecretion and all non-suppressors were hypersecretors. Medknow Publications 1986 /pmc/articles/PMC3172529/ /pubmed/21927174 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Reddy, M. Saikumar
Kuruvilla, K.
DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
title DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
title_full DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
title_fullStr DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
title_full_unstemmed DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
title_short DEXAMETHASONE SUPPRESSION TEST IN DEPRESSION
title_sort dexamethasone suppression test in depression
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172529/
https://www.ncbi.nlm.nih.gov/pubmed/21927174
work_keys_str_mv AT reddymsaikumar dexamethasonesuppressiontestindepression
AT kuruvillak dexamethasonesuppressiontestindepression